Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

CME profits fall as low rate environment hits hedging demand

Published 07/29/2020, 07:35 AM
Updated 07/29/2020, 11:50 AM
© Reuters. Men enter the CME Group offices in New York
NDAQ
-
CME
-

By John McCrank

NEW YORK (Reuters) - CME Group (O:CME), the world's biggest futures exchange operator, on Wednesday said its quarterly profit fell as steps taken by the U.S. government to ease the economic impact of the coronavirus pandemic curbed hedging demand for some of its top products.

The Chicago Board of Trade-owner's net income was $503.3 million, or $1.40 per diluted share, down from $513.8 million, or $1.43 per diluted share, a year earlier.

The COVID-19 pandemic has spurred volatility in equity markets, benefiting some exchange operators, like Nasdaq Inc (O:NDAQ), which last week reported better-than-expected earnings as stock and options trading volume soared.

But CME's volumes were mostly down, after the U.S. Federal Reserve flooded the markets with liquidity in response to the pandemic and said interest rates would stay near zero for the foreseeable future, reducing the demand for hedging through futures on rates, commodities and currencies.

While interest rates have experienced "unprecedented low volatility" across the yield curve in response to the Fed's actions, the longer-term outlook for interest rate futures is positive, said Sean Tully, a senior managing director at CME.

"Once the Federal Reserve reduces its intervention in the market and once the pandemic recedes, the needs for hedging, the needs for our products, are going to be much, much larger, I think, than ever before in history," he said on a call with analysts.

Clearing and transaction fees, CME's biggest revenue stream, fell 10.6% to $940.2 million from a year earlier as the company's average daily volume tumbled 15.8% to 17.6 million contracts.

Revenue from CME's market data and information services business rose 5% to $134.7 million.

Total revenue fell 7.1% from a year earlier to $1.18 billion.

© Reuters. Men enter the CME Group offices in New York

Stripping out one-time items like acquisition costs, CME earned $1.63 per share, topping analysts expectations by a penny, according to IBES data from Refinitiv.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.